• Panel: Advances towards Cannabis Regulation

    Undeniable that a strong movement towards the regulation of the cannabis market is emerging
    6th Latin American and 1st Caribbean Conference on Drug Policy
    Wednesday, October 5, 2016

    In spite of the prejudices and legal obstacles that persist in relation to a legal market for cannabis, it is undeniable that a strong movement towards the regulation of the cannabis market is emerging. On this premise we look for a way to construct tools and debate the pros and cons that are presented by the regulation of such a market. Including the usage of medical and traditional uses of cannabis, the right to grow, social grow clubs, the situation of farmers and the of responses of governments to this reality.

  • Cannabis and the Conventions: UNGASS and Beyond

    Cannabis is clearly the elephant in the room at UNGASS
    Conference Room B, United Nations Headquarters, April 20, 2016

    ungass2016_nyWith an increasing number of jurisdictions enacting or contemplating reforms creating legal access to cannabis for purposes other than exclusively "medical and scientific," tensions regarding the drug conventions and evolving law and practice in Member States continue to grow. How might the UN system address these growing tensions in ways that acknowledge the policy shifts underway and explore options that reinforce the UN pillars of human rights, development, peace and security, and the rule of law?

    Download the flyer (PDF)

  • Cannabis Science and Policy Summit 2016

    New York City, April 17-18, 2016

    cannabis-summitWith California and other states likely to vote on full cannabis legalization, decisions made in 2016 may well shape the future of cannabis policy for a generation or more. Scientists, policy thinkers, journalists, industry leaders, and advocates came together at the Cannabis Science and Policy Summit 2016 on April 17 and 18 in New York City for a discussion of what is happening, what is likely to happen, and what should be done in the world of cannabis legalization. Martin Jelsma and Tom Blickman of TNI participated in two different panels.

  • Civil society urges EU leadership on drug policy ahead of UNGASS

    “Budapest Group” releases recommendations on EU engagement at 2016 UN General Assembly Special Session (UNGASS)
    Budapest, July 21, 2015

    The Budapest Group is a network of European NGOs working in the field of drug policy reform, including Harm Reduction International, the Global Drug Policy Program of the Open Society Foundations (OSF), the International Federation of Red Cross and Red Crescent Societies (IFRC), Transform Drug Policy Foundation, the International Drug Policy Consortium (also hear public policy alumna Gloria Lai on the topic here), the Hungarian Civil Liberties Union, and the Transnational Institute.

  • Exploring the land-drugs nexus

    Land is one of the key factors of production in the drug economy
    European Development Days, June 4, 2015

    Opium poppy field in Gostan valley, Nimruz Province, Afghanistan"For many communities in Myanmar who grow opium, for them opium is not the problem, it is the solution to their problems," said local project consultant, Tom Kramer, from the Transnational Institute. And therein lies one of the greatest challenges for policy makers in the fight to eradicate the scourge of drug crops in developing countries. Most drug crop cultivating areas are greatly affected by poverty, physical isolation, landlessness, insecure land rights and conflicts over natural resources. For many poor farmers, the cultivation of drug crops represents a coping mechanism to prevail in difficult environments.

  • CND 2015 Side Event: E-Book of Authorities

    E-Book of Authorities launched at 2015 CND to support international drug policy debates and negotiations

    e-bookThe “E-Book of Authorities” is a civil society-led project to catalogue agreed UN statements and language on a selection of key topics. It aims to show the extent of existing international support for evidence-based drug policies, and to support international drug policy discussions, debates and negotiations.

    Visit the E-Book of Authorities



Page 1 of 3